ES2656082T3 - NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular - Google Patents
NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular Download PDFInfo
- Publication number
- ES2656082T3 ES2656082T3 ES12794941.0T ES12794941T ES2656082T3 ES 2656082 T3 ES2656082 T3 ES 2656082T3 ES 12794941 T ES12794941 T ES 12794941T ES 2656082 T3 ES2656082 T3 ES 2656082T3
- Authority
- ES
- Spain
- Prior art keywords
- subject
- sample
- tia
- amount
- transient ischemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11191579 | 2011-12-01 | ||
| EP11191579 | 2011-12-01 | ||
| PCT/EP2012/073897 WO2013079567A2 (en) | 2011-12-01 | 2012-11-29 | Nt-proanp and nt-probnp for the diagnosis of stroke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2656082T3 true ES2656082T3 (es) | 2018-02-23 |
Family
ID=47278813
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12794941.0T Active ES2656082T3 (es) | 2011-12-01 | 2012-11-29 | NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular |
| ES17196637T Active ES2899923T3 (es) | 2011-12-01 | 2012-11-29 | NT-proANP y NT-proBNP para el diagnóstico de apoplejía |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17196637T Active ES2899923T3 (es) | 2011-12-01 | 2012-11-29 | NT-proANP y NT-proBNP para el diagnóstico de apoplejía |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10732188B2 (https=) |
| EP (2) | EP3290924B1 (https=) |
| JP (2) | JP6059735B2 (https=) |
| CN (2) | CN104094121B (https=) |
| CA (2) | CA2856461C (https=) |
| ES (2) | ES2656082T3 (https=) |
| WO (1) | WO2013079567A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016056664A1 (ja) * | 2014-10-10 | 2016-04-14 | 松森 昭 | 心不全患者の検出方法、心疾患の識別方法、心不全の検査試薬、心不全の検査キット、心不全を検出するための装置及び心不全を検出するためのプログラム |
| KR20210038893A (ko) * | 2018-07-31 | 2021-04-08 | 에프. 호프만-라 로슈 아게 | 심방 세동의 평가에서 순환하는 dkk3(딕오프 관련 단백질 3) |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| JP7698310B2 (ja) * | 2019-05-16 | 2025-06-25 | フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ | 再灌流療法のために患者を選択する方法 |
| JP2021173559A (ja) | 2020-04-21 | 2021-11-01 | 株式会社デンソー | 物理量計測装置 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| ATE458199T1 (de) | 2001-05-04 | 2010-03-15 | Biosite Inc | Diagnostische marker der akuten koronaren syndrome und ihre verwendungen |
| JP2005522669A (ja) * | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | 卒中および脳損傷の診断マーカーおよびその使用方法 |
| WO2004059293A2 (en) * | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| ATE462001T1 (de) * | 2002-12-24 | 2010-04-15 | Nitto Boseki Co Ltd | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit |
| US20050181386A1 (en) * | 2003-09-23 | 2005-08-18 | Cornelius Diamond | Diagnostic markers of cardiovascular illness and methods of use thereof |
| EP1582597A1 (en) | 2004-03-29 | 2005-10-05 | Aventis Pharma Deutschland GmbH | Method of diagnosis of a predisposition to develop thrombotic disease and its uses |
| US20060166303A1 (en) * | 2005-01-24 | 2006-07-27 | Eberhard Spanuth | Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs |
| EP1849009B1 (en) | 2005-01-24 | 2008-10-29 | F. Hoffmann-La Roche AG | The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs. |
| WO2006087373A1 (en) * | 2005-02-17 | 2006-08-24 | F. Hoffmann-La Roche Ag | Use of nt-proanp/nt-probnp ratio for diagnosing cardiac dysfunctions |
| EP1731910A1 (en) * | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| DE102005048899A1 (de) * | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| DE602006014798D1 (de) * | 2006-03-24 | 2010-07-22 | Roche Diagnostics Gmbh | Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten |
| EP1882945A1 (en) | 2006-07-28 | 2008-01-30 | F.Hoffmann-La Roche Ag | Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath |
| EP1901072B1 (en) * | 2006-09-15 | 2009-11-25 | F. Hoffman-la Roche AG | Biochemical markers for acute pulmonary embolism |
| EP2210111A1 (en) | 2007-10-10 | 2010-07-28 | Roche Diagnostics GmbH | Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome |
| CN102257386B (zh) * | 2008-10-24 | 2014-12-31 | B.R.A.H.M.S有限公司 | 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估 |
| US8486652B2 (en) * | 2009-01-30 | 2013-07-16 | Bio-Rad Innovations | Method for the in vitro diagnosis of stroke |
| EP2466311A1 (en) | 2010-12-17 | 2012-06-20 | Roche Diagnostics GmbH | sFlt1 in patients with ischemic stroke |
-
2012
- 2012-11-29 CN CN201280068882.4A patent/CN104094121B/zh active Active
- 2012-11-29 ES ES12794941.0T patent/ES2656082T3/es active Active
- 2012-11-29 WO PCT/EP2012/073897 patent/WO2013079567A2/en not_active Ceased
- 2012-11-29 CN CN201610812599.8A patent/CN107064516B/zh active Active
- 2012-11-29 ES ES17196637T patent/ES2899923T3/es active Active
- 2012-11-29 CA CA2856461A patent/CA2856461C/en active Active
- 2012-11-29 EP EP17196637.7A patent/EP3290924B1/en active Active
- 2012-11-29 CA CA3081979A patent/CA3081979C/en active Active
- 2012-11-29 JP JP2014543882A patent/JP6059735B2/ja active Active
- 2012-11-29 EP EP12794941.0A patent/EP2786154B1/en active Active
-
2014
- 2014-05-30 US US14/291,676 patent/US10732188B2/en active Active
-
2016
- 2016-12-09 JP JP2016239317A patent/JP6441885B2/ja active Active
-
2020
- 2020-06-30 US US16/916,809 patent/US20200333360A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA3081979C (en) | 2023-07-11 |
| EP3290924B1 (en) | 2021-10-13 |
| WO2013079567A2 (en) | 2013-06-06 |
| WO2013079567A3 (en) | 2013-08-29 |
| JP2015504519A (ja) | 2015-02-12 |
| JP6059735B2 (ja) | 2017-01-11 |
| JP2017075959A (ja) | 2017-04-20 |
| JP6441885B2 (ja) | 2018-12-19 |
| EP3290924A1 (en) | 2018-03-07 |
| EP2786154A2 (en) | 2014-10-08 |
| CN104094121A (zh) | 2014-10-08 |
| US10732188B2 (en) | 2020-08-04 |
| CN107064516B (zh) | 2019-08-02 |
| CA3081979A1 (en) | 2013-06-06 |
| US20140274793A1 (en) | 2014-09-18 |
| CN107064516A (zh) | 2017-08-18 |
| HK1201327A1 (en) | 2015-08-28 |
| US20200333360A1 (en) | 2020-10-22 |
| ES2899923T3 (es) | 2022-03-15 |
| CA2856461A1 (en) | 2013-06-06 |
| CN104094121B (zh) | 2016-10-26 |
| CA2856461C (en) | 2020-08-18 |
| EP2786154B1 (en) | 2017-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2656082T3 (es) | NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular | |
| ES2380440T3 (es) | Marcador para fallo de injerto y mortalidad | |
| ES2676553T3 (es) | IGFBP7 para el diagnóstico de la disfunción diastólica | |
| ES2774288T3 (es) | Diagnóstico basado en TnT o BNP de fibrilación auricular paroxística | |
| ES2913539T3 (es) | Identificación de pacientes con fracción de acortamiento anómala | |
| ES2824110T3 (es) | Troponina como marcador de fibrilación auricular intermitente | |
| JP6934508B2 (ja) | 心不全におけるスタチン治療階層化のためのマーカー | |
| ES2549460T3 (es) | NT-pro ANP y sFlt-1 para la diferenciación entre los eventos isquémicos y circulatorios | |
| ES2352351T3 (es) | Métodos para la estratificación de la insuficiencia cardiaca. | |
| ES2977423T3 (es) | Angiopoyetina-2 (Ang-2) circulante y proteína de unión al factor de crecimiento insulínico 7 (IGFBP7) para la predicción de apoplejía | |
| HK1241021B (zh) | 用於诊断中风的nt-原anp和nt-原bnp | |
| HK1201327B (en) | Nt-proanp and nt-probnp for the diagnosis of stroke | |
| HK1241021A1 (en) | Nt-proanp and nt-probnp for the diagnosis of stroke | |
| HK1196158B (en) | Troponin and bnp based diagnosis of risk patients and cause of stroke |